BioLargo unwinds 2018 Scion deal, transfers SkinDisc IP back, cancels $1.25M note

BIOLARGO, INC.

BioLargo and Clyra assign SkinDisc IP (patents, trademark) back to Scion; Scion keeps 2M BioLargo shares.
Scion forgives $1.25M promissory note principal ($1.007M outstanding) plus $152,716 accrued interest.
Scion returns 31,000 Clyra shares; Clyra cancels $305,450 in consulting debts owed to Brown, Rhodes, Liden.
Spencer Brown resigns from Clyra board; five-year non-compete on copper-iodine vs SkinDisc tech.
Mutual releases of all claims; BioLargo converts $633,091 Clyra advances into 2,042 Clyra shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.